Advances in crossboss/stingray use in antegrade dissection reentry from the Asia pacific chronic total occlusion club
EB Wu, ES Brilakis, S Lo… - Catheterization and …, 2020 - Wiley Online Library
Antegrade dissection reentry with Stingray device (Boston Scientific, Marlborough, MA)
accounts for 20–34% of the chronic total occlusion (CTO) cases in the various hybrid …
accounts for 20–34% of the chronic total occlusion (CTO) cases in the various hybrid …
[HTML][HTML] Antegrade Chronic total occlusion crossing: CrossBoss First or last?
The CrossBoss-Stingray antegrade dissection and re-entry (ADR) system (Boston Scientific,
Natick, Massachusetts) was designed to help overcome a common failure mode of …
Natick, Massachusetts) was designed to help overcome a common failure mode of …
Antegrade dissection and reentry as part of the hybrid chronic total occlusion revascularization strategy: a subanalysis of the RECHARGE Registry (Registry of …
J Maeremans, J Dens, JC Spratt… - Circulation …, 2017 - Am Heart Assoc
Background—Development of the CrossBoss and Stingray devices for antegrade dissection
and reentry (ADR) of chronic total occlusions has improved historically suboptimal …
and reentry (ADR) of chronic total occlusions has improved historically suboptimal …
[HTML][HTML] Initial experience and feasibility of the new low-profile stingray catheter as part of the antegrade dissection and re-entry revascularization strategy for coronary …
J Maeremans, PJ Palmers, J Dens - The American Journal of Case …, 2017 - ncbi.nlm.nih.gov
Objective: Unusual setting of medical care Background: During antegrade dissection re-
entry (ADR) of chronic total occlusions (CTO), the first-generation Stingray catheter requires …
entry (ADR) of chronic total occlusions (CTO), the first-generation Stingray catheter requires …
[PDF][PDF] Proximal optimization technique facilitates wire entry into stumpless chronic total occlusion of side branch
K Yokoi, S Sonoda, G Yoshioka, K Jojima… - JACC: Cardiovascular …, 2021 - Elsevier
Percutaneous coronary intervention (PCI) for a chronically total occlusion (CTO) lesion is still
one of the most challenging procedures. Especially in the case of a stumpless CTO lesion of …
one of the most challenging procedures. Especially in the case of a stumpless CTO lesion of …
[HTML][HTML] Antegrade chronic total occlusion strategies: a technical focus for 2020
C Creaney, SJ Walsh - Interventional Cardiology Review, 2020 - ncbi.nlm.nih.gov
Chronic total occlusions (CTOs) are common in patients with ischaemic heart disease. In
many countries, patients with CTOs are underserved by percutaneous coronary intervention …
many countries, patients with CTOs are underserved by percutaneous coronary intervention …
Antegrade dissection and reentry: tools and techniques
RM Wyman - Interventional cardiology clinics, 2012 - Elsevier
Coronary artery chronic total occlusions (CTO) remain the most challenging lesion subset for
percutaneous intervention. Despite a growing body of evidence relating to poor long-term …
percutaneous intervention. Despite a growing body of evidence relating to poor long-term …
A new algorithm for crossing chronic total occlusions from the Asia Pacific Chronic Total Occlusion Club
SA Harding, EB Wu, S Lo, ST Lim, L Ge… - JACC: Cardiovascular …, 2017 - jacc.org
Although the hybrid chronic total occlusion (CTO) algorithm had many excellent
recommendations, there has been infrequent adoption in the Asia Pacific region. The Asia …
recommendations, there has been infrequent adoption in the Asia Pacific region. The Asia …
Trends and outcomes of antegrade dissection and re-entry in chronic total occlusion percutaneous coronary intervention
Background The contemporary frequency and outcomes of antegrade dissection and re-
entry (ADR) for chronic total occlusion (CTO) percutaneous coronary intervention (PCI) have …
entry (ADR) for chronic total occlusion (CTO) percutaneous coronary intervention (PCI) have …
Long-term outcomes with use of the CrossBoss and stingray coronary CTO crossing and re-entry devices.
O Mogabgab, VG Patel, TT Michael, E Fuh… - The Journal of …, 2013 - europepmc.org
Background The Boston Scientific CrossBoss and Stingray Coronary CTO Crossing and Re-
Entry devices (formerly the BridgePoint Medical System) can improve success rates in …
Entry devices (formerly the BridgePoint Medical System) can improve success rates in …